News Center

Earlier this month, we had the privilege of hearing firsthand from Isabelle Lousada about her journey to an AL amyloidosis diagnosis nearly 30 years ago and her successful stem cell transplant. After achieving complete remission, Isabelle founded the Amyloidosis Research Consortium (ARC) with the goal of uniting different stakeholders to improve outcomes for patients with […]

At Prothena, we feel fortunate to hear from patients whose stories inspire us to continue to innovate for those who are in dire need of new treatment options. Each story fuels our commitment to keep patients and their needs at the forefront of our efforts. We are equally grateful for our relationships with advocacy organizations, […]

Prothena recently reported fourth quarter and full year 2024 financial results, another successful year of progress in our effort to address unmet needs for the millions of patients and their loved ones that are affected by devastating, life-threatening diseases caused by protein dysregulation. With many of our clinical programs nearing significant inflection points in 2025, […]